Carboplatin resistant human laryngeal carcinoma cells are cross resistant to curcumin due to reduced curcumin accumulation

Toxicology in Vitro

Volumn 27, Issue 2, 2013, Pages 523-532

  Rak, Sanjica ^a   Čimbora Zovko, Tamara ^a   Gajski, Goran ^b   Dubravčić, Klara ^c   Domijan, Ana Marija ^d   DelaŠ, Ivančica ^e   Garaj Vrhovac, Verica ^b   Batinić, Drago ^c   Sorić, Jasna ^d   Osmak, Maja ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^c KBC Zagreb   (Croatia)

^d UNIVERSITY OF ZAGREB   (Croatia)

^e UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Cellular accumulation; Curcumin; DNA damage; Drug resistance; Lipid peroxidation; ROS

Indexed keywords

BINDING PROTEIN; CARBOPLATIN; CURCUMIN; DNA; FATTY ACID; HEAT SHOCK PROTEIN 70; LIPID; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL LINE; CROSS RESISTANCE; DNA DAMAGE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LARYNX CARCINOMA; LIPID COMPOSITION; LIPID PEROXIDATION; MOLECULAR MECHANICS; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARBOPLATIN; CARCINOMA; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; DNA DAMAGE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FATTY ACIDS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LARYNGEAL NEOPLASMS; LIPID PEROXIDATION; REACTIVE OXYGEN SPECIES;

EID: 84875269579     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.11.003     Document Type: Article

References (52)

1. Atsumi T., Fujisawa S., Tonosaki K. Relationship between intracellular ROS production and membrane mobility in curcumin- and tetrahydrocurcumin-treated human gingival fibroblasts and human submandibular gland carcinoma cells. Oral Dis. 2005, 11:236-242.
2. Bachmeier B.E., Iancu C.M., Killian P.H., Kronski E., Mirisola V., Angelini G., Jochum M., Nerlich A.G., Pfeffer U. Overexpression of the ATP binding cassette gene ABCA1 determines resistance to curcumin in M14 melanoma cells. Mol. Cancer 2009, 8:129.
3. Binaschi M., Zunino F., Capranico G. Mechanism of action of DNA topoisomerase inhibitors. Stem Cells 1995, 13:369-379.
4. Burns C.P., North J.A. Adriamycin transport and sensitivity in fatty acid-modified leukemia cells. Biochim. Biophys. Acta 1986, 888:10-17.
5. Cao J., Jia L., Zhou H.M., Liu Y., Zhong L.F. Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. Toxicol. Sci. 2006, 91:476-483.
6. Carmody R.J., Cotter T.G. Signalling apoptosis: a radical approach. Redox Rep. 2001, 6:77-90.
7. Casas A., Di Venosa G., Hasan T., Al B. Mechanisms of resistance to photodynamic therapy. Curr. Med. Chem. 2011, 18:2486-2515.
8. Champoux J.J. DNA topoisomerases: structure, function, and mechanism. Annu. Rev. Biochem. 2001, 70:369-413.
9. Chattopadhyay I., Biswas K., Bandyopadhyay U., Banerjee R.K. Turmeric and curcumin: biological actions and medicinal applications. Curr. Sci. 2004, 87:44-53.
10. Chen Q., Wang Y., Xu K., Lu G., Ying Z., Wu L., Zhan J., Fang R., Wu Y., Zhou J. Curcumin induces apoptosis in human lung adenocarcinoma A549 cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Oncol. Rep. 2010, 23:397-403.
11. Circu M.L., Aw T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radical Biol. Med. 2010, 48:749-762.
12. Das U.N., Madhavi N., Sravan Kumar G., Padma M., Sangeetha P. Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites?. Prostaglandins Leukot. Essent. Fatty Acids 1998, 58:39-54.
13. Deeley R.G., Westlake C., Cole S.P. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol. Rev. 2006, 86:849-899.
14. Fodale V., Pierobon M., Liotta L., Petricoin E. Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance?. Cancer J. 2011, 17:89-95.
15. FujisawaIshihara S., Fujisawa M., Kadoma Y. Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. Anticancer Res. 2004, 24:563-569.
16. Gajski G., Garaj-Vrhovac V., Orescanin V. Cytogenetic status and oxidative DNA-damage induced by atorvastatin in human peripheral blood lymphocytes: standard and Fpg-modified comet assay. Toxicol. Appl. Pharmacol. 2008, 231:85-93.
17. Gottesman M.M. Mechanisms of cancer drug resistance. Annu. Rev. Med. 2002, 53:615-627.
18. Hail N. Mitochondrial reactive oxygen species affect sensitivity to curcumin-induced apoptosis. Free Radical Biol. Med. 2008, 44:1382-1393.
19. Halliwell B., Gutteridge J.M. Free Radicals in Biology and Medicine 1999, Oxford University Press, Midsomer Norton, Avon, UK. third ed.
20. Huang A.C., Chang C.L., Yu C.S., Chen P.Y., Yang J.S., Ji B.C., Lin T.P., Chiu C.F., Yeh S.P., Huang Y.P., Lien J.C., Chung J.G. Induction of apoptosis by curcumin in murine myelomonocytic leukemia WEHI-3 cells is mediated via endoplasmic reticulum stress and mitochondria-dependent pathways. Environ. Toxicol. 2011, 10.1002/tox.20716.
21. Jakopec S., Dubravcic K., Polanc S., Kosmrlj J., Osmak M. Diazene JK-279 induces apoptosis-like cell death in human cervical carcinoma cells. Toxicol. In Vitro 2006, 20:217-226.
22. Jaruga E., Salvioli S., Dobrucki J., Chrul S., Bandorowicz-Pikula J., Sikora E., Franceschi C., Cossarizza A., Bartosz G. Apoptosis-like, reversible changes in plasma membrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytes. FEBS Lett. 1998, 433:287-293.
23. Jiang Z., Jin S., Yalowich J.C., Brown K.D., Rajasekaran B. The mismatch repair system modulates curcumin sensitivity through induction of DNA strand breaks and activation of G2-M checkpoint. Mol. Cancer Ther. 2010, 9:558-568.
24. Kang J., Chen J., Shi Y., Jia J., Zhang Y. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. Biochem. Pharmacol. 2005, 69:1205-1213.
25. Karunagaran D., Rashmi R., Kumar T.R. Induction of apoptosis by curcumin and its implications for cancer therapy. Curr. Cancer Drug Targets 2005, 5:117-129.
26. Khar A., Ali A.M., Pardhasaradhi B.V., Varalakshmi C.H., Anjum R., Kumari A.L. Induction of stress response renders human tumor cell lines resistant to curcumin-mediated apoptosis: role of reactive oxygen intermediates. Cell Stress Chaperones 2001, 6:368-376.
27. Khopde S.M., Priyadarsini K.I., Palit D.K., Mukherjee T. Effect of solvent on the excited-state photophysical properties of curcumin. Photochem. Photobiol. 2000, 72:625-631.
28. Kohen R., Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol. Pathol. 2002, 30:620-650.
29. Kunnumakkara A.B., Anand P., Aggarwal B.B. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008, 269:199-225.
30. Kunwar A., Barik A., Mishra B., Rathinasamy K., Pandey R., Priyadarsini K.I. Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. Biochim. Biophys. Acta 2008, 1780:673-679.
31. Labbozzetta M., Notarbartolo M., Poma P., Maurici A., Inguglia L., Marchetti P., Rizzi M., Baruchello R., Simoni D., D'Alessandro N. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer. Ann. N.Y. Acad. Sci. 2009, 1155:278-283.
32. Lin S.S., Huang H.P., Yang J.S., Wu J.Y., Hsia T.C., Lin C.C., Lin C.W., Kuo C.L., Gibson Wood W., Chung J.G. DNA damage and endoplasmic reticulum stress mediated curcumin-induced cell cycle arrest and apoptosis in human lung carcinoma A-549 cells through the activation caspases cascade- and mitochondrial-dependent pathway. Cancer Lett. 2008, 272:77-90.
33. Lopez-Lazaro M. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol. Nutr. Food Res. 2008, 52(Suppl 1):S103-127.
34. Lopez-Lazaro M., Willmore E., Jobson A., Gilroy K.L., Curtis H., Padget K., Austin C.A. Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells. J. Nat. Prod. 2007, 70:1884-1888.
35. Lu J.J., Cai Y.J., Ding J. The short-time treatment with curcumin sufficiently decreases cell viability, induces apoptosis and copper enhances these effects in multidrug-resistant K562/A02 cells. Mol. Cell. Biochem. 2012, 360:253-260.
36. Mickisch G., Fajta S., Keilhauer G., Schlick E., Tschada R., Alken P. Chemosensitivity testing of primary human renal cell carcinoma by a tetrazolium based microculture assay (MTT). Urol. Res. 1990, 18:131-136.
37. Onda T., Toyoda E., Miyazaki O., Seno C., Kagaya S., Okamoto K., Nishikawa K. NK314, a novel topoisomerase II inhibitor, induces rapid DNA double-strand breaks and exhibits superior antitumor effects against tumors resistant to other topoisomerase II inhibitors. Cancer Lett. 2008, 259:99-110.
38. Osmak M., Bizjak L., Jernej B., Kapitanovic S. Characterization of carboplatin-resistant sublines derived from human larynx carcinoma cells. Mutat. Res. 1995, 347:141-150.
39. Peetla C., Bhave R., Vijayaraghavalu S., Stine A., Kooijman E., Labhasetwar V. Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids. Mol. Pharm. 2010, 7:2334-2348.
40. Rashmi R., Santhosh Kumar T.R., Karunagaran D. Human colon cancer cells differ in their sensitivity to curcumin-induced apoptosis and heat shock protects them by inhibiting the release of apoptosis-inducing factor and caspases. FEBS Lett. 2003, 538:19-24.
41. Rashmi R., Kumar S., Karunagaran D. Ectopic expression of Hsp70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis. Carcinogenesis 2004, 25:179-187.
42. Rose H.G., Oklander M. Improved procedure for the extraction of lipids from human erythrocytes. J. Lipid Res. 1965, 6:428-431.
43. Silver J.T., Noble E.G. Regulation of survival gene hsp70. Cell Stress Chaperones 2012, 17:1-9.
44. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
45. Sordet O., Khan Q.A., Kohn K.W., Pommier Y. Apoptosis induced by topoisomerase inhibitors. Curr. Med. Chem. Anticancer Agents 2003, 3:271-290.
46. 2+ and the activation of caspase-3. Anticancer Res. 2006, 26:4379-4389.
47. Sung B., Kunnumakkara A.B., Sethi G., Anand P., Guha S., Aggarwal B.B. Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. Mol. Cancer Ther. 2009, 8:959-970.
48. Teiten M.H., Eifes S., Dicato M., Diederich M. Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins (Basel) 2010, 2:128-162.
49. Urbina-Cano P., Bobadilla-Morales L., Ramirez-Herrera M.A., Corona-Rivera J.R., Mendoza-Magana M.L., Troyo-Sanroman R., Corona-Rivera A. DNA damage in mouse lymphocytes exposed to curcumin and copper. J. Appl. Genet. 2006, 47:377-382.
50. Wang F., Wu X., Wang F., Liu S., Jia Z., Yang J. The sensitive fluorimetric method for the determination of curcumin using the enhancement of mixed micelle. J. Fluoresc. 2006, 16:53-59.
51. Wang Y.J., Pan M.H., Cheng A.L., Lin L.I., Ho Y.S., Hsieh C.Y., Lin J.K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 1997, 15:1867-1876.
52. Weir N.M., Selvendiran K., Kutala V.K., Tong L., Vishwanath S., Rajaram M., Tridandapani S., Anant S., Kuppusamy P. Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol. Ther. 2007, 6:178-184.